Landing Point Financial Group LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,026 shares of the healthcare conglomerate's stock, valued at approximately $1,069,000. UnitedHealth Group makes up about 0.8% of Landing Point Financial Group LLC's investment portfolio, making the stock its 16th biggest holding.
Several other hedge funds have also added to or reduced their stakes in UNH. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $6,375,744,000. Raymond James Financial Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi grew its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. Proficio Capital Partners LLC lifted its stake in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Capital International Investors increased its position in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the company. Morgan Stanley decreased their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a report on Tuesday. Oppenheimer cut their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday. HSBC reissued a "hold" rating and issued a $490.00 price target on shares of UnitedHealth Group in a report on Tuesday. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Finally, Truist Financial lowered their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $603.05.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Trading Down 0.7 %
NYSE UNH traded down $2.86 during mid-day trading on Thursday, reaching $425.10. 3,642,925 shares of the stock were exchanged, compared to its average volume of 5,627,220. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a 50 day simple moving average of $506.92 and a 200-day simple moving average of $537.23. UnitedHealth Group Incorporated has a one year low of $417.12 and a one year high of $630.73. The stock has a market cap of $388.85 billion, a P/E ratio of 27.43, a P/E/G ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business earned $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.